Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Medical Oncology
•
Thrombosis
•
Hematology
•
Benign Hematology
•
Hemostasis/Thrombosis
Would you anticoagulate an SMV thrombosis caused by malignant obstruction in the setting of metastatic colorectal cancer?
Related Questions
Is there a role for DOAC use for patients with unprovoked PE, that have had recent sleeve gastrectomy with duodenal bypass?
What is your clinical threshold for treating a potential monoclonal gammopathy of thrombotic significance?
Do you routinely evaluate for PE if a DVT is found?
How would you manage superficial thrombophlebitis of the great saphenous vein involving the knee and calf?
For patients with newly diagnosed VTE on IV heparin planned for transition to DOAC, would you start at the loading or maintenance DOAC dose?
Is there any benefit of using aspirin to mitigate VTE risk in testosterone-induced polycythemia?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
How would you manage symptomatic, bilateral subsegmental PE developed after long air travel?
Would you recommend anticoagulation in subsequent pregnancies after symptomatic postpartum R ovarian vein thrombosis?
What is your approach to symptomatic superficial thrombosis of the pelvic veins occurring in the immediate postpartum period?
